The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Will adding alkylating agent to bortezomib improve survival of newly diagnosed AL amyloidosis patients?
 
Yumeng Zhang
No Relationships to Disclose
 
Lauren Duncanson
No Relationships to Disclose
 
Taiga Nishihori
Research Funding - Celgene (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Doris K. Hansen
No Relationships to Disclose
 
Jose L. Ochoa-Bayona
No Relationships to Disclose
 
Hien D Liu
No Relationships to Disclose
 
Rachid C. Baz
Consulting or Advisory Role - Celgene; Karyopharm Therapeutics
Research Funding - Abbvie (Inst); Celgene (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst); Signal Genetics (Inst); Takeda (Inst)
 
Brandon Jamaal Blue
No Relationships to Disclose